2024
DOI: 10.1016/j.bcp.2024.116174
|View full text |Cite
|
Sign up to set email alerts
|

Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke

Liu Yang,
Lauren Guttman,
Valina L. Dawson
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 214 publications
0
0
0
Order By: Relevance
“…Parthanatos, however, is independent of caspase activation and dependent on PARP activation; thus, it can be rescued with PARP inhibitors. Parthanatos has been mostly studied in the context of neurodegenerative diseases and stroke, in which it was first described ( 42 , 46 ). However, recent findings indicate that cancer cells are also susceptible to parthanatos ( 47 , 48 ), which represents a therapeutic opportunity to kill cancer cells that are resistant to other types of death.…”
Section: Introductionmentioning
confidence: 99%
“…Parthanatos, however, is independent of caspase activation and dependent on PARP activation; thus, it can be rescued with PARP inhibitors. Parthanatos has been mostly studied in the context of neurodegenerative diseases and stroke, in which it was first described ( 42 , 46 ). However, recent findings indicate that cancer cells are also susceptible to parthanatos ( 47 , 48 ), which represents a therapeutic opportunity to kill cancer cells that are resistant to other types of death.…”
Section: Introductionmentioning
confidence: 99%